Overview: Cancer Early Detection Advanced Research (CEDAR) Center is a collaborative institution within the OHSU Knight Cancer Institute at OHSU. The Knight Cancer Institute, known as one of the pioneers in personalized cancer medicine, is an international leader in research and cancer treatment. At CEDAR, our mission is to precisely detect and stop lethal cancers at the earliest stage because early detection saves lives. This is an ambitious goal, one that requires novelty, creativity, and innovation. CEDAR funds our own research projects, expediting the process of discovery.
Our Commitment to Diversity: CEDAR is committed to increasing the diversity of the campus community. We are dedicated to promoting inclusion and multiculturalism by having outstanding researchers of diverse backgrounds work together on multiple projects. We encourage high-risk, high-reward research projects because defeating cancer requires out-of-the-box thinking and new perspectives. Our research is milestone driven to ensure that each project is fulfilling its stated goals.
Every Knight Cancer employee is expected to embody our guiding principles:
The OHSU Fellowship for Diversity in Research seeks to address the need for increased representation of minoritized races/ethnicities in STEM at the postdoctoral level. Eligible candidates are encouraged to apply. Visit www.ohsu.edu/ofdir for more information.
CEDAR is currently seeking applicants to fill multiple postdoctoral positions for computational and/or wet lab research. CEDAR offers a unique opportunity for outstanding, driven, and creative postdoctoral fellows to perform cutting-edge and high-risk research, ranging from understanding basic cancer biology and mechanisms to developing novel approaches and technologies for detection, computational analysis or therapeutic intervention.
How to apply:
#indeed #linkedin #knightpostdocjobs #knightcancerjobs
tissue engineering, microfluidics, microfabrication, bioprinting, cancer cell biology and materials science, DNA methylation and histone modifications, cell signaling, gene expression, T cell, immune system, liquid biopsy, proteomics, organoids, organs-on-a-chip, Dielectrophoresis (DEP), nanoparticles, nanoengineering, immunotherapy, tumor microenvironment, prolyl isomerase PIN1, cell-free RNA (cfRNA), extracellular vesicles (EVs), anti-cancer immunity, B cell, Scanning Electron Microscopy (SEM), Focused Ion Beam (FIB-SEM) nuclear processes, DNA replication, transcription, cellular repair, cell cycle, 3D, bioprinting, HER2, microscopy, imaging, epigenomes, transcriptomics, chromatin, single-cell, multi-omics, transcriptional regulation, 3D genome folding, protein engineering, synthetic chemistry.
Oregon Health & Science University values a diverse and culturally competent workforce. We are proud of our commitment to being an equal opportunity, affirmative action organization that does not discriminate against applicants on the basis of any protected class status, including disability status and protected veteran status. Individuals with diverse backgrounds and those who promote diversity and a culture of inclusion are encouraged to apply. To request reasonable accommodation contact the Affirmative Action and Equal Opportunity Department at 503-494-5148 or email@example.com.